| Mrs Kristin M Gallop, NURSE PRACTITIONER | |
|
59 Bangor St, Houlton, ME 04730-1740 | |
| (207) 538-3700 | |
| Not Available |
| Full Name | Mrs Kristin M Gallop |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 59 Bangor St, Houlton, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336165356 | NPI | - | NPPES |
| Entity Name | Katahdin Valley Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376618546 PECOS PAC ID: 4880659903 Enrollment ID: O20041130000688 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Professor Fiona Watt will today (12 July) give the Anne McLaren Memorial Lecture at the UK National Stem Cell Network annual science meeting and will detail a new approach to screening for drugs that target stem cells. To begin with, this is being developed for adult skin stem cells, giving hope for new drugs to promote wound healing and aid the use of stem cells to, for example, treat severe burns. This technique can also be applied to a wide range of stem cells, opening up the possibilities for harnessing stem cells in regenerative medicine.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread (tenofovir disoproxil fumarate).
In a recent brief report published in the prestigious New England Journal of Medicine, researchers from the Rockefeller University in New York described a case of two fully vaccinated individuals in whom they found subsequent breakthrough infections with variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), carrying a number of substitutions of interest.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kristin M Gallop, NURSE PRACTITIONER 529 S Patten Rd, Patten, ME 04765-3007 Ph: (207) 538-3700 | Mrs Kristin M Gallop, NURSE PRACTITIONER 59 Bangor St, Houlton, ME 04730-1740 Ph: (207) 538-3700 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Professor Fiona Watt will today (12 July) give the Anne McLaren Memorial Lecture at the UK National Stem Cell Network annual science meeting and will detail a new approach to screening for drugs that target stem cells. To begin with, this is being developed for adult skin stem cells, giving hope for new drugs to promote wound healing and aid the use of stem cells to, for example, treat severe burns. This technique can also be applied to a wide range of stem cells, opening up the possibilities for harnessing stem cells in regenerative medicine.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread (tenofovir disoproxil fumarate).
In a recent brief report published in the prestigious New England Journal of Medicine, researchers from the Rockefeller University in New York described a case of two fully vaccinated individuals in whom they found subsequent breakthrough infections with variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), carrying a number of substitutions of interest.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 6 days ago
Kaitlin Anne Koppel, MSN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 22 Hartford St, Houlton, ME 04730 Phone: 207-532-3289 | |
Mrs. Linda Haines Self, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 22 Hartford St, Houlton, ME 04730 Phone: 207-532-3289 Fax: 207-532-6071 | |
Shelby Jean Stiles, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 20 Hartford St, Houlton, ME 04730 Phone: 207-429-8333 | |
Jamieson F Romanelli, PMHNP/MSN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 59 Bangor St, Houlton, ME 04730 Phone: 207-538-3700 Fax: 207-528-2595 | |
Tory Rouse, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 22 Hartford St, Houlton, ME 04730 Phone: 207-532-7936 Fax: 207-532-7937 | |
Nancy Y Putnam, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22 Hartford St, Houlton, ME 04730 Phone: 207-532-3289 Fax: 207-532-6071 |